N. V. Ivanov

N. V. Ivanov

Auto-generated profile, based on publicly available information

N. V. Ivanov

Mechnikov North-Western State Medical University, Ministry of Health of the Russian Federation; Andijan State Medical Institute; Medsi Group of Companies JSC

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
NIN. V. Ivanov
N. V. Ivanov
KAK. Z. Amandullaev
K. Z. Amandullaev
SYSh. K. Yusupova
Sh. K. Yusupova
SVS. V. Vykhodtsev
S. V. Vykhodtsev
EME. V. Medvedeva
E. V. Medvedeva
Introduction . Azoospermia, defined as the absence of spermatozoa in the ejaculate after centrifugation, is one of the leading causes of male infertility, affecting approximately 1,0 % of men in the general population and up to 15,0 % of infertile patients. Timely differentiation between obstructive (ОА) and non-obstructive (NOA) azoospermia is critical for selecting appropriate treatment strategies, determining prognosis, and applying assisted reproductive technologies (ART). Aim : to investigate the prevalence of different azoospermia forms of azoospermia in infertile men, within the context of real-world clinical practice at a non-specialized endocrine outpatient department, including personal observations, with consideration of/in comparison with the results of international and Russian epidemiological studies. Materials and Methods . A comprehensive analysis of literature, clinical guidelines, and original data was performed. The study included 450 men aged 25–45 years with confirmed azoospermia. All patients underwent a comprehensive examination, including collection of anamnesis (reproductive, somatic, surgical); physical examination with assessment of secondary sexual characteristics, size and consistency of the testicles; double examination of ejaculate (centrifugation, microscopy); examination of blood hormone levels (follicle-stimulating hormone, luteinizing hormone, total testosterone, prolactin, anti-Müllerian hormone, sex hormone-binding globulin, inhibin B; if indicated – estradiol, thyroid-stimulating hormone, thyroxine); scrotum ultrasound examination with Doppler ultrasonography; genetic testing – karyotyping, testing for microdeletions of Y chromosome azoospermia factor ( AZF ) of the Y chromosome, CFTR (cystic fibrosis transmembrane conductance regulator) gene testing; when indicated, testicular sperm extraction (TESE) biopsy was performed. Results . NOA and OA were identified in 63.3 % and 30 % of patients, respectively. Among NOA cases, the leading causes were idiopathic forms (19.6 %), Klinefelter syndrome (8.4 %), Y-chromosome microdeletions (5.8 %), and hypogonadotropic hypogonadism (6.7 %). Varicocele was associated with NOA in 12 % of cases. These findings are consistent with global data, although minor ethnic and methodological differences were observed. Conclusion . Azoospermia is a clinically and etiologically heterogeneous condition. Timely differentiation between its forms and the inclusion of genetic testing improve diagnostic accuracy and help optimizing management strategies. Standardization of diagnostic algorithms and a personalized approach increase ART effectiveness and the likelihood of fertility restoration.

1 January 2022 in Juvenis scientia
Verified
Journal Article
Open access
PDF file
NKN. V. Khudyakova
N. V. Khudyakova
IPIvan Pchelin
Ivan Pchelin
ASA. N. Shishkin
A. N. Shishkin
NIN. V. Ivanov
N. V. Ivanov
VSV. V. Smirnov
V. V. Smirnov
VVVolha Vasilkova
Volha Vasilkova
Spina bifida is a developmental defect of the spinal cord and / or spine that results from abnormal closure of the embryonic neural tube. Many factors have been described to determine the risks of developing this pathology, but the incidence of the defect is still high. 61 % of patients with Spina bifida have neurogenic bladder dysfunction based on intravesical hypertension, which contributes to reverse urethral flow and bladder-uretero-renal reflux associated with chronic inflammatory and obstructive urinary tract disease. In 25–50 % of patients with Spina bifida, urological pathology is complicated by the development of chronic kidney disease, which significantly reduces the quality of life of these patients. In some types of Spina bifida, urological symptoms may be prominent or even isolated and may indicate the presence of the malformation. Therefore, early diagnosis of Spina bifida and timely prophylactic and therapeutic measures are of particular importance.

2 December 2023 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
NKN. V. Khudyakova
N. V. Khudyakova
IPIvan Pchelin
Ivan Pchelin
ASA. N. Shishkin
A. N. Shishkin
SMS. O. Mazurenko
S. O. Mazurenko
VVV. A. Volovnikova
V. A. Volovnikova
VVVolha Vasilkova
Volha Vasilkova
Adrenoleukodystrophy (ALD) is the most common peroxisomal disease of X-linked recessive inheritance caused by a mutation in the ABCD 1 gene located on chromosome Xq28. A characteristic feature of ALD is the lack of correlation between genotype and phenotype. Depending on the time of onset, the main manifestations, and the rate of symptom progression, there are 6 main forms of the disease, but the most common is adrenomyeloneuropathy (AMN). When carefully examining patients with AMI, in most cases it is possible to identify urological pathology manifested by overactive bladder in both sexes and hypogonadism in men, which are hidden behind other numerous neurological symptoms and often remain undiagnosed. To date, there are few works devoted to the peculiarities of pathogenesis, clinical course, diagnosis and treatment of this pathology in ALD. In this article, we reviewed the current literature data on neurogenic bladder dysfunction and hypogonadism in ALD.

19 January 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
EME. V. Medvedeva
E. V. Medvedeva
NIN. V. Ivanov
N. V. Ivanov
AVA. F. Vesnina
A. F. Vesnina
EKE. A. Khromova
E. A. Khromova
SYSh. K. Yusupova
Sh. K. Yusupova
Here, we summarize current evidence on the impact of postmenopausal osteoporosis, menopause-related hormonal changes, and hormone therapy on dental implant outcomes. Epidemiology and pathogenesis of bone alterations are reviewed, with particular emphasis on the role of estrogen, progesterone, calcitonin, growth hormone, and insulin-like growth factor-1 (IGF-1) deficiency. Special attention is paid to the effects of menopausal hormone therapy and bioidentical forms of estradiol and progesterone on osteoporosis course and the effectiveness of dental implantation. The analysis highlights the risks of implant loss and the opportunities of interdisciplinary approach in dentistry and endocrinology to optimize implant osseointegration in postmenopausal women.

5 September 2023 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
NIN. V. Ivanov
N. V. Ivanov
ISI. P. Serebryakova
I. P. Serebryakova
NKN. V. Khudyakova
N. V. Khudyakova
AFA. I. Fedorova
A. I. Fedorova
The literature review is dedicated to the topical subject in current endocrinology and gynecology – clitoromegaly. At present, clitoromegaly is considered as a symptom of an endocrinological disease associated with impaired testosterone or androgen production. However, in most cases, the cause of the disease cannot be determined. A condition described in the clitoromegaly classification as an "idiopathic clitoromegaly" holds a leading place. Despite an opportunity to perform a successful clitoroplasty in childhood, adult patients with clitoromegaly quite often seek specialists` help. Such girls and women often suffer from anxietydepressive disorders related to social maladjustment associated due to sexological and psychological problems, which requires a sexologist or psychotherapist` supervision and treatment. Here, we provide the data on genetic syndromes accompanied by clitoromegaly. Differential diagnostics algorithms for neonates, young and adult women are proposed.

20 May 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
NHN. V. Hudiakova
N. V. Hudiakova
IPIvan Pchelin
Ivan Pchelin
ASA. N. Shishkin
A. N. Shishkin
PVP. V. Vasilev
P. V. Vasilev
NSN. Yu. Semigolovskii
N. Yu. Semigolovskii
NIN. V. Ivanov
N. V. Ivanov
In this article, we described а clinical case of a 32-year-old patient with late diagnosis of adrenomyeloneuropathy manifested with gradually increasing neurologic symptoms, mistakenly considered as hereditary spastic paraparesis, later joined by adrenal insufficiency. It is known that ALD is characterized by a pronounced phenotypic polymorphism, which is associated with differences in penetrance and expression of the abnormal gene. The patient was examined for pathogenic mutations associated with spastic paraplegia and hereditary diseases with similar phenotypic manifestations (Neurodegenerative Diseases panel including analysis of 723 genes). No significant changes meeting the search criteria were found. However, the absence of point mutations associated with ALD does not exclude this diagnosis, but requires the exclusion of chromosomal rearrangements by sequencing the ABCD1 gene. This study was not performed on the patient, which subsequently led to the misdiagnosis. Despite the fact that current clinical guidelines allow the diagnosis of ALD without genetic confirmation, due to the variety of ALD “masks” and frequent untimely diagnosis of this disease, sequencing of the ABCD1 gene is advisable. In order to correct adrenal insufficiency, the patient was prescribed hormone replacement therapy (HRT) with hydrocortisone, which eliminated the main clinical manifestations and partially laboratory signs of hypocorticism. However, corticotropin levels indicated inadequacy of HRT and increased risk of secondary corticotropinoma growth. However, the patient has been receiving intrathecal therapy with the GABA agonist baclofen for the past five years. The literature has not yet described the response of stress hormones to intrathecal administration of baclofen in patients with primary hypocorticism. The few data available indicate that GABA agonists may have a multidirectional effect on hypothalamic-pituitary function; therefore, it is difficult to determine the contribution of this effect on corticotropin secretion in this patient.